BioGlyph
BioGlyph helps scientists design and evaluate biologic molecules faster using an AI-powered, format-agnostic platform. It provides an intuitive drag-and-drop interface, support for antibody standards such as AbML and VERITAS, and a library of protein building blocks to compose complex molecules. The platform includes an AI module for multispecific antibodies (MsAbs) that runs in-silico simulations to predict molecular fitness and developability across large panels. Delivered as a SaaS product, BioGlyph integrates AI, domain-specific markup standards, and protein engineering workflows for biologics R&D. Its customers are primarily biologics researchers at biotech companies and academic labs aiming to accelerate discovery and candidate selection.
BioGlyph
BioGlyph helps scientists design and evaluate biologic molecules faster using an AI-powered, format-agnostic platform. It provides an intuitive drag-and-drop interface, support for antibody standards such as AbML and VERITAS, and a library of protein building blocks to compose complex molecules. The platform includes an AI module for multispecific antibodies (MsAbs) that runs in-silico simulations to predict molecular fitness and developability across large panels. Delivered as a SaaS product, BioGlyph integrates AI, domain-specific markup standards, and protein engineering workflows for biologics R&D. Its customers are primarily biologics researchers at biotech companies and academic labs aiming to accelerate discovery and candidate selection.